COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
COMPANION
COMPANION Study: A Pilot Trial Testing Couple Mindfulness-based Cognitive Behavioral Therapy Via Internet Targeting Cancer-related Fatigue [Workpackage 2]
3 other identifiers
interventional
68
1 country
2
Brief Summary
Chronic cancer-related fatigue (CCRF) is a disturbing condition that persists in up to 25% of cancer patients after completion of treatment. While mindfulness-based interventions are effective in relieving CCRF, these typically target the patient alone. Growing evidence suggests that including partners and targeting the dyadic context can increase and broaden the interventions' efficacy. The proposed study is a pilot trial testing the acceptability and potential efficacy of a mindfulness intervention directed at couples.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2022
CompletedFirst Submitted
Initial submission to the registry
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
December 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2024
CompletedJuly 25, 2023
July 1, 2023
1.3 years
October 31, 2022
July 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of the couple eMBCT operationalized as intervention adherence
Operationalized as percentage of couples in which the patient completed the intervention and the partner did not drop out from it. Patients' intervention completion will be recorded in the therapist log and assessed by patient self-report. If either one satisfies the completion criterion, the couple will be considered as intervention completers. Benchmark: \>= 60% of couples completed the intervention.
Throughout intervention completion, about 15-20 weeks per couple
Acceptability of the couple eMBCT operationalized as satisfaction with the intervention
Quantitatively operationalized as satisfaction with the dyadic approach and the intervention overall (score \>= 5 indicates satisfaction, (couples only, not therapists) as assessed at T1, 2 weeks after intervention completion. Benchmark: \>= 70% of patients and 70% of partners indicating on the T1 questionnaire to be satisfied.
Throughout intervention completion, about 15-20 weeks per couple
Potential efficacy on patient fatigue as assessed with the fatigue severity subscale of the Checklist Individual Strength (CIS-fatigue) from pre-intervention (T0) to 2 weeks post-intervention (T1)
Fatigue is assessed with the Checklist Individual Strength, subscale fatigue severity (CIS-fatigue) on T0 (pre-intervention) and T1 (approx. 2 weeks after intervention completion). Eight items are rated on a 7-point scale, measuring fatigue in the preceding 2 weeks. The scale score ranges between 8 and 56, with a higher score indicating a higher level of fatigue. 1. Change in patient fatigue. The change in fatigue from T0 to T1 is tested with a matched pairs t-test and according to the intention-to-treat principle. Benchmark: a statistically significant (p \< .05) decrease in patient fatigue between T0 and T1. 2. Clinically relevant change in patient fatigue. Operationalized as a reduction on the CIS-fatigue from T0 to T1 of at least 6-points. Benchmark: ≥ 45% of patients score on T1 at least 6 points lower than on T0.
From the pre-intervention baseline assessment (Timepoint 0) to the post-intervention assessment, 2 weeks after intervention completion (Timepoint 1)
Secondary Outcomes (4)
Feasibility of trial procedures operationalized as recruitment rate
Throughout study conduction, i.e. during the (planned) total of 18 months of data collection
Feasibility of trial procedures operationalized as T1 and T2 assessment adherence rate
Throughout study conduction, i.e. during the (planned) total of 18 months of data collection
Feasibility of trial procedures operationalized as diary adherence rate
Throughout study conduction, i.e. during the (planned) total of 18 months of data collection
Potential working mechanisms of couple eMBCT
During diary period, 17-22 weeks
Study Arms (1)
couple eMBCT
EXPERIMENTALThe couple eMBCT has nine sessions, takes 15-20 weeks, can be followed from home and will be supervised remotely by a trained therapist. Consistent with the original (patient-only) eMBCT, the couple eMBCT aims to change the patient's behavioral and cognitive reactions to fatigue and other cancer-related stressors. Couple eMBCT includes information for partners each session, the possibility for partners to perform exercises and one session specifically dedicated to the couple's mutual relationship and mindful communication about CCRF. Couples can determine themselves to which degree the partner is involved in the therapy.
Interventions
'Samen Minder Moe' is a mindfulness-based cognitive behavioral therapy for cancer-related fatigue directed at couples.
Eligibility Criteria
You may qualify if:
- Only couples are eligible for participation. In order to be eligible, the couple must meet each of the following criteria:
- The patient has received a cancer diagnosis (all malignancies will be included);
- The patient completed cancer treatment with either curative or palliative intent ≥ 3 months earlier. Patients who currently receive hormone therapy are eligible;
- The patient experiences severe levels of fatigue (score of ≥ 35 on the Checklist Individual Strength, subscale fatigue severity (CIS-fatigue));
- The patient has been suffering from severe fatigue for ≥ 3 months (as self-reported by the patient);
- The patient was ≥ 18 years old at disease onset;
- The partner is ≥ 18 years old;
- Both couple members live together;
- Both couple members have good command of the Dutch language (checked implicitly during registration);
- Both couple members have adequate computer literacy and have access to an internet-connected computer, laptop or tablet (based on self-report);
- Both couple members agree to participate in the research.
You may not qualify if:
- The couple will be excluded in case:
- The patient is currently following an evidence-based therapy for CCRF (i.e. Cognitive-Behavioral Therapy, mindfulness-based therapy, exercising/physiotherapy) as self-reported at the (telephone) screening;
- The patient suffers from a condition that can explain his/her fatigue and is potentially treatable (e.g. anemia);
- The therapist decides, based on information collected during the intake session, that the intervention is not suitable for the couple. Criteria that will be considered include, but are not limited to:
- presence of substance abuse, except for smoking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mariët Hagedoornlead
- Helen Dowling Institutecollaborator
Study Sites (2)
Helen Dowling Institute
Bilthoven, 3723 MB, Netherlands
University Medical Center Groningen
Groningen, 9700 RB, Netherlands
Related Publications (1)
Muller F, van Dongen S, van Woezik R, Tibosch M, Tuinman MA, Schellekens MPJ, Laurenceau JP, van der Lee M, Hagedoorn M. A Web-Based Mindfulness-Based Cognitive Therapy for Couples Dealing With Chronic Cancer-Related Fatigue: Protocol for a Single-Arm Pilot Trial. JMIR Res Protoc. 2023 Nov 6;12:e48329. doi: 10.2196/48329.
PMID: 37930767DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mariët Hagedoorn, PhD
University Medical Center Groningen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
October 31, 2022
First Posted
December 5, 2022
Study Start
September 21, 2022
Primary Completion
January 21, 2024
Study Completion
March 21, 2024
Last Updated
July 25, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After study completion and publication of outcome data.
- Access Criteria
- The anonymized data that support the findings of this study will become available from the principle investigators upon reasonable request, including a data analysis plan and research questions. Permission for data sharing will be asked from the medical ethical commission.
Collected quantitative IPD (questionnaires, diaries) can potentially be shared.